| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |